International journal of gynaecology and obstetrics : the official organ of the International Federation of Gynaecology and Obstetrics
-
Int J Gynaecol Obstet · Jul 2020
ReviewDelivery in pregnant women infected with SARS-CoV-2: A fast review.
Few case reports and clinical series exist on pregnant women infected with SARS-CoV-2 who delivered. ⋯ The rate of vertical or peripartum transmission of SARS-CoV-2 is low, if any, for cesarean delivery; no data are available for vaginal delivery. Low frequency of spontaneous preterm birth and general favorable immediate neonatal outcome are reassuring.
-
Int J Gynaecol Obstet · Nov 2019
Meta AnalysisA systematic review and meta-analysis of randomized controlled trials comparing 17-alpha-hydroxyprogesterone caproate versus placebo for the prevention of recurrent preterm birth.
Preterm birth causes an increased risk for perinatal morbidity and mortality. ⋯ CDR42017082190.
-
Int J Gynaecol Obstet · Oct 2019
Meta AnalysisA systematic review and meta-analysis of thermal coagulation compared with cryotherapy to treat precancerous cervical lesions in low- and middle-income countries.
Thermal coagulation is gaining popularity for treating cervical intraepithelial neoplasia (CIN) in screening programs in low- and middle-income countries (LMICs) due to unavailability of cryotherapy. ⋯ Both cryotherapy and thermal coagulation are effective treatment modalities for CIN lesions in LMICs.
-
Cervical cancer is currently the fourth leading cause of cancer death among women worldwide, with most cases occurring in low- and middle-income countries. Safe, highly effective vaccines against HPV have been on the market since 2006, yet only 6% of girls worldwide have received this life-saving cancer prevention intervention. International organizations, including PATH, Gavi, and the pharmaceutical companies Merck and GlaxoSmithKline, have provided support to eligible low- and middle-income countries to implement national HPV vaccination programs. ⋯ We also present three emerging solutions to transform future HPV vaccine delivery in low- and middle-income countries: low-cost generics, single-dose vaccination, and co-administration with other adolescent vaccines. By rapidly expanding access to HPV vaccination to girls everywhere, vaccine-type HPV infections can be virtually eliminated. At high vaccination-coverage levels, more than 80%-or approximately 230 000-of the cervical cancer deaths that occur each year can be averted.
-
Int J Gynaecol Obstet · Jan 2017
ReviewA systematic review of implementation strategies to deliver guidelines on obstetric care practice in low- and middle-income countries.
Healthcare measures to prevent maternal deaths are well known. However, effective implementation of this knowledge to change practice remains a challenge. ⋯ CRD42014010310.